Trial · NCT02336607
Results by group80
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 80
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 14 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Metoprolol Tablet (Betaloc ZOK) | 74.1 | 95% Confidence Interval 64.5 to 83.6 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 14 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablets (Plendil)+Lisinopril (Zestril) | 80.5 | 95% Confidence Interval 71.7 to 89.4 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 14 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Hydrochlorothiazide | 80.2 | 95% Confidence Interval 71.8 to 88.6 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 14 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil) | NA | 95% Confidence Interval NA to NA | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Metoprolol Tablet (Betaloc ZOK) | 45.8 | 95% Confidence Interval 35.1 to 56.5 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablets (Plendil)+Lisinopril (Zestril) | 59.5 | 95% Confidence Interval 49 to 70 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Hydrochlorothiazide | 46.2 | 95% Confidence Interval 35.9 to 56.4 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil) | NA | 95% Confidence Interval NA to NA | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 8 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Metoprolol Tablet (Betaloc ZOK) | 78.6 | 95% Confidence Interval 69.8 to 87.3 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 8 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablets (Plendil)+Lisinopril (Zestril) | 79 | 95% Confidence Interval 70.1 to 87.9 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 8 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Hydrochlorothiazide | 78.7 | 95% Confidence Interval 70.1 to 87.2 | Percentage | |
| The Percentage of Subjects Reaching Blood Pressure Target (Defined as < 140 / 90 mmHg) After 8 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil) | NA | 95% Confidence Interval NA to NA | Percentage | |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Metoprolol Tablet (Betaloc ZOK) | Change of systolic blood pressure | -10.3 | Standard Deviation 2.0 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablets (Plendil)+Lisinopril (Zestril) | Change of systolic blood pressure | -13.4 | Standard Deviation 1.8 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Hydrochlorothiazide | Change of systolic blood pressure | -9.8 | Standard Deviation 1.4 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil) | Change of systolic blood pressure | NA | Standard Deviation NA | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Metoprolol Tablet (Betaloc ZOK) | Change of diastolic blood pressure | -7.3 | Standard Deviation 1.5 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablets (Plendil)+Lisinopril (Zestril) | Change of diastolic blood pressure | -9.9 | Standard Deviation 1.4 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil)+Hydrochlorothiazide | Change of diastolic blood pressure | -6.0 | Standard Deviation 1.0 | mmHg |
The Magnitude of Systolic and Diastolic Blood Pressure Change From Baseline Among All Randomized Subjects After 4 Weeks of Felodipine Sustained Release in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide. | Felodipine Tablet (Plendil) | Change of diastolic blood pressure | NA | Standard Deviation NA | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02336607/results